AndreaBozzo/ceres-open-data-index huggingface dataset:
Patent AT-E399644-T1: [Translated] INKJET NOZZLE ARRANGEMENT WITH ACTUATING MECHANISM IN CHAMBER BETWEEN NOZZLE AND INK SUPPLY

An inkjet nozzle arrangement is provided. The arrangement comprises a nozzle chamber having an ink ejection port defined in a wall of the nozzle chamber, an ink supply channel for the supply of ink to the nozzle chamber, and an actuator located in the nozzle chamber, between the ink supply channel and the ink ejection port. The actuator is adapted to cause ejection of ink from the nozzle chamber upon activation.
NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable

NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable - 2021. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notice: Due to data processing issues at CDC, data for the following jurisdictions may be incomplete for week 7: Alaska, Arizona, California, Connecticut, Delaware, Florida, Hawaii, Louisiana, Maryland, Michigan, Missouri, North Dakota, New Hampshire, New York City, Oregon, Pennsylvania, and Rhode Island.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
  * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data). 
§ Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.
Measurement of Suicidal Thoughts, Behaviors, and Related Health Outcomes in the United States: Comparison of NSDUH Estimates with Other Data Sources

This report compares estimates of suicidality (i.e., serious thoughts of suicide, suicide plans, suicide attempts, and receipt of medical care for a suicide attempt) generated from the 2008-2012 National Survey on Drug Use and Health (NSDUH) with estimates of similar measures acquired from other national data sources: National Comorbidity Survey Replication (NCS-R), the Youth Risk Behavior Survey (YRBS), the National Hospital Discharge Survey (NHDS), and the Nationwide Inpatient Sample (NIS). Results are shown by gender, race/ethnicity, age, and year data collected.
Compound 527280: Agn-PC-0jsddh

Chemical compound data from PubChem database. IUPAC Name: 2,5,6-trimethylhepta-1,3,6-triene. Molecular Formula: C10H16. Molecular Weight: 136.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527020: N-Benzyl butanoyl fentanyl

Chemical compound data from PubChem database. IUPAC Name: N-(1-benzylpiperidin-4-yl)-N-phenylbutanamide. Molecular Formula: C22H28N2O. Molecular Weight: 336.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hospital Inpatient Discharges (SPARCS De-Identified): Inpatient Quality Indicators (IQI) Composite Measures by Hospital: Beginning 2009

The datasets contain hospital discharges counts (numerators, denominators, volume counts), observed, expected and risk-adjusted rates with corresponding 95% confidence intervals for IQIs generated using methodology developed by Agency for Healthcare Research and Quality (AHRQ).
The IQIs are a set of measures that provide a perspective on hospital quality of care using hospital administrative data. These indicators reflect quality of care inside hospitals and include inpatient mortality for certain procedures and medical conditions; utilization of procedures for which there are questions of overuse, underuse, and misuse; and volume of procedures for which there is some evidence that a higher volume of procedures is associated with lower mortality.
All the IQI measures were calculated using Statewide Planning and Research Cooperative System (SPARCS) inpatient data beginning 2009. US Census data files provided by AHRQ were used to derive denominators for county level (area level) IQI measures.

The mortality, volume and utilization measures IQIs are presented by hospital as rates or counts. Area-level utilization measures are presented by county as rates.
Patent AT-E401521-T1: [Translated] ACTUATING ARRANGEMENT FOR ACTUATING A VALVE ARRANGEMENT

The assembly has a valve adjusting unit (16) moved between adjusting positions using an electromagnetic actuator (14). A valve adjusting lever (18) is coupled with the unit (16) via a slide that is supported in the unit (16). The actuator has an anchor section (40) that is supported in a coil arrangement and is displaced in an axial direction during excitation of the arrangement. A guide sleeve (60) made of a soft-magnetic material is fixed in the arrangement. An outer surface of the section is coated with friction-resistant material Teflon(RTM: Polytetrafluoroethylene). An independent claim is also included for an electromagnetic actuator for a valve arrangement.
Service Area PUF - PY2015

The Service Area PUF (SA-PUF) is one of the seven files that make up the Marketplace PUF. The SA-PUF contains issuer-level data on the geographic coverage or service area (i.e., where the plan is offered) including state, county, and zip code. These data either originate from the Service Area template (i.e., template field), an Excel based form used by issuers to describe their plans in the QHP/SADP application process, or were generated by CCIIO for use in data processing (i.e., system-generated).
Public Health Statistics - Screening for elevated blood lead levels in children aged 0-6 years by year, Chicago, 1999-2013 - Historical

Note: This dataset is historical only and there are not corresponding datasets for more recent time periods. For that more-recent information, please visit the Chicago Health Atlas at https://chicagohealthatlas.org.

This dataset contains the annual number and estimated rate per 1,000 children aged 0-6 years receiving a blood lead level test, and the annual number and estimated percentage of those tested found to have an elevated blood lead level, with corresponding 95% confidence intervals, by Chicago community area, for the years 1999 – 2013.  See the full dataset description for more information at https://data.cityofchicago.org/api/views/gpjh-i4j2/files/vIHuTqqgxDT1UFX9XhgCeYddaOhsG2nzgoMLUoRjeOI?download=true&filename=P:\EPI\OEPHI\MATERIALS\REFERENCES\LEAD_POISONING\Dataset_Description_BloodLeadTesting_1999-2013.pdf
Compound 527716: Isobutyl 2,3-dibromopropanoate

Chemical compound data from PubChem database. IUPAC Name: 2-methylpropyl 2,3-dibromopropanoate. Molecular Formula: C7H12Br2O2. Molecular Weight: 287.98. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530779: p-Methoxybenzoic acid, 2-bromo-4-fluorophenyl ester

Chemical compound data from PubChem database. IUPAC Name: (2-bromo-4-fluorophenyl) 4-methoxybenzoate. Molecular Formula: C14H10BrFO3. Molecular Weight: 325.13. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2013 CMHS Uniform Reporting System (URS) Table for Washington

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for Washington for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Living Clinical Guidelines for Infection-Associated Chronic Conditions and Illnesses (IACCIs)

Join HHS and LymeX collaborators in the <a href="https://invisibleillness.crowdicity.com/hubbub/communitypage/23445">Living Clinical Guidelines for IACCIs</a> ecosystem to cocreate solutions with patients as partners for Long COVID, Lyme disease, ME/CFS, and other complex chronic conditions that are often invisible illnesses.
National Youth Survey US:  Wave IV (NYS-1979)

<p>Youth data for the fourth wave of the National Youth Survey<br />
are contained in this data collection. The first wave of this survey<br />
was conducted in 1976, the second wave in 1977, and the third wave in 1978. Data are available in<br />
this wave on the demographic and socioeconomic status of respondents,<br />
disruptive events in the home, youth aspirations and expectations,<br />
social isolation, normlessness, perceived disapproval by parents and<br />
peers, attitudes toward deviance, exposure and commitment to delinquent<br />
peers, sex roles, interpersonal violence, pressure for substance abuse<br />
by peers, self-reported delinquency, drug and alcohol use, and<br />
victimization.This study has 1 Data Set.</p>
Patent AT-E4011-T1: [Translated] ELECTRICAL CONNECTION AND METHOD OF MAKING SUCH CONNECTION.

A plug receptacle electrical connector and a method of manufacturing such a connector. The receptacle connector comprises a moulded insulating cover (1) which receives a moulded insulating base (36) carrying electrical contacts (60) for engaging contacts of a plug connector (100) inserted into a cavity (2) in the cover (1). To enable the connector to be mounted on a circuit board with the contacts (60) connected to circuitry (not shown) on the board, the contacts (60) have lead portions (64) which project beneath the base (36), the bottom of the cover (36) being open to receive the lead portions (64). Rails (48) on the base (36), which engage in grooves (82 and 88) in the cover, being provided on the sides of the base (36) and having thereon latches (50) for engaging shoulders (52A) defined by the grooves (82 and 88). In the manufacture of the connector, the contacts (60) are selectively plated with gold stripes (not shown) for engagement by the contacts of the plug (100).
Nearly Half of Substance Abuse Treatment Facilities Offer Counseling or Medication to Help Clients Quit Tobacco Use

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) spotlight showing the number of substance abuse treatment facilities that offer counseling or medication to help clients quit tobacco use in 2012. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
U.S. State and Territorial Orders Closing and Reopening Restaurants Issued from March 11, 2020 through May 31, 2021 by County by Day

State and territorial executive orders, administrative orders, resolutions, and proclamations are collected from government websites and cataloged and coded using Microsoft Excel by one coder with one or more additional coders conducting quality assurance.

Data were collected to determine when restaurants in states and territories were subject to closing and reopening requirements through executive orders, administrative orders, resolutions, and proclamations for COVID-19. Data can be used to determine when restaurants in states and territories were subject to closing and reopening requirements through executive orders, administrative orders, resolutions, and proclamations for COVID-19. Data consists exclusively of state and territorial orders, many of which apply to specific counties within their respective state or territory; therefore, data is broken down to the county level.

These data are derived from publicly available state and territorial executive orders, administrative orders, resolutions, and proclamations (“orders”) for COVID-19 that expressly close or reopen restaurants found by the CDC, COVID-19 Community Intervention & Critical Populations Task Force, Monitoring & Evaluation Team, Mitigation Policy Analysis Unit, and the CDC, Center for State, Tribal, Local, and Territorial Support, Public Health Law Program from March 11, 2020 through May 31, 2021.  These data will be updated as new orders are collected. Any orders not available through publicly accessible websites are not included in these data. Only official copies of the documents or, where official copies were unavailable, official press releases from government websites describing requirements were coded; news media reports on restrictions were excluded. Recommendations not included in an order are not included in these data. Effective and expiration dates were coded using only the date provided; no distinction was made based on the specific time of the day the order became effective or expired. These data do not necessarily represent an official position of the Centers for Disease Control and Prevention.
Compound 528702: 2-Cyclopenten-1-one, 2-hydroxy-4-methyl

Chemical compound data from PubChem database. IUPAC Name: 2-hydroxy-4-methylcyclopent-2-en-1-one. Molecular Formula: C6H8O2. Molecular Weight: 112.13. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Minneapolis: Drug-Related Emergency Department Visits, 2004-2011 - Accidental Ingestions

Excel file with estimates, rates, relative standard errors, trends and confidence intervals, covering 2004-2011 for emergency department visits involving accidental ingestions in the Minneapolis metropolitan area. This analytic category includes ED visits in which an individual accidentally or unknowingly used or was administered a prescription drug, over-the-counter medication, or dietary supplement. Drug-related accidental ingestion typically involves patients aged 5 and under.  This analytic category does not include drug misuse or abuse.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Compound 526534: [7-(hydroxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-2-yl] 2-methylbut-2-enoate

Chemical compound data from PubChem database. IUPAC Name: [7-(hydroxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-2-yl] 2-methylbut-2-enoate. Molecular Formula: C13H19NO3. Molecular Weight: 237.29. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Identification ofSchistosoma mansonigender-associated gene transcripts by cDNA microarray profiling

Parasitic helminths of the genusSchistosomamate, achieve sexual maturity and produce eggs in the bloodstream of their definitive hosts, and the most important pathological consequences of the infection are associated with this process. We have used cDNA microarray technology to initiate genome-wide gene-expression studies of sex and sexual development in matureSchistosoma mansoniparasites.
Tribal TANF Caseload Data

Federally recognized Indian tribes can apply for funding to administer and operate their own TANF programs. Data includes recipient counts by tribe and month (total, by family type, by adjult, and by child). Data may be downloaded by year, and further by Total Recipients, Families, Adults, and Children (PDF, 5 pages each)

<b>Units of Response: </b>Tribal TANF Programs

<b>Type of Data: </b>Administrative

<b>Tribal Data: </b>Yes

<b>COVID-19 Data: </b>No

<b>Periodicity: </b>Annual

<b>SORN: </b>Not Applicable

<b>Data Use Agreement: </b>Unavailable

<b>Data Use Agreement Location: </b>Unavailable

<b>Equity Indicators: </b>Indigenous Population

<b>Granularity: </b>Tribe

<b>Spatial: </b>United States

<b>Geocoding: </b>Region;Tribe
Patent AT-E401306-T1: [Translated] PYRROLE DERIVATIVE

A novel pyrrole derivative represented by the following formula (1) and a salt thereof: <CHEM> wherein R<1> means substituted alkenyl, etc.; R<2> means substituted benzoyl, etc.; and R<3> to R<5> each means hydrogen, alkyl, halogeno, etc. The derivative and salt have antidiabetic activity.
Compound 525413: 2-Methyl-4,6-dithiaheptane

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-1-(methylsulfanylmethylsulfanyl)propane. Molecular Formula: C6H14S2. Molecular Weight: 150.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525187: Triethylene glycol, monoallyl ether, acetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-(2-prop-2-enoxyethoxy)ethoxy]ethyl acetate. Molecular Formula: C11H20O5. Molecular Weight: 232.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530480: 5-Chlorovaleric acid, 2-adamantyl ester

Chemical compound data from PubChem database. IUPAC Name: 2-adamantyl 5-chloropentanoate. Molecular Formula: C15H23ClO2. Molecular Weight: 270.79. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525878: N,N-Dimethyl-N'-(3-methylphenyl)-isobutyramidine

Chemical compound data from PubChem database. IUPAC Name: N,N,2-trimethyl-N'-(3-methylphenyl)propanimidamide. Molecular Formula: C13H20N2. Molecular Weight: 204.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528571: 1,2,3-Propanetricarboxylic acid, 2-[(tert-butyldimethylsilyl)oxy]-, tris(tert-butyldimethylsilyl) ester

Chemical compound data from PubChem database. IUPAC Name: tris[tert-butyl(dimethyl)silyl] 2-[tert-butyl(dimethyl)silyl]oxypropane-1,2,3-tricarboxylate. Molecular Formula: C30H64O7Si4. Molecular Weight: 649.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528753: 4,6-Decadiyn-1-ol isovalerate

Chemical compound data from PubChem database. IUPAC Name: deca-4,6-diynyl 3-methylbutanoate. Molecular Formula: C15H22O2. Molecular Weight: 234.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400626-T1: [Translated] SILICONE COMPOSITION AND POLYMER DISPERSED LIQUID CRYSTAL

A silicone composition comprising a liquid crystal containing two para-phenylene groups, and a polymer dispersed liquid crystal (PDLC) prepared by a method comprising curing the aforementioned silicone composition, wherein the PDLC is transparent and has a refractive index of from 1.42 to 1.6 at 25 °C for light having a wavelength of 589 mn.
Compound 529338: 1H-Imidazole, 4-methyl-1-propyl

Chemical compound data from PubChem database. IUPAC Name: 4-methyl-1-propylimidazole. Molecular Formula: C7H12N2. Molecular Weight: 124.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Micafungin

Micafungin is an antifungal medication belonging to the echinocandin class, used to treat fungal infections. It comes as an injectable powder for intravenous infusion, available in strengths like 50 mg and 100 mg per vial. Manufactured by Glenmark Pharmaceuticals Inc., USA, it's a prescription drug approved under ANDA219273. This information was generated using AI and is provided for informational and research purposes only.
Hospital Cost Report Audited Data: 2014

This version of the Institutional Cost Report (ICR) has been audited by a Certified Public Accounting Firm. The ICR is a uniform report completed by New York State hospitals to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations, (Part 86-1.2), Article 28 hospitals are required to file financial and statistical data with DOH annually. The data filed is part of the ICR and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends. For more information, check out: http://www.health.ny.gov/facilities/hospital/index.htm
National Directory of Drug and Alcohol Abuse Treatment Facilities - 1997

The National Directory of Drug and Alcohol Abuse Treatment Programs 1997 lists federal, state, local, and private facilities that provide substance abuse treatment services. The directory includes treatment facilities that are licensed, certified, or otherwise approved for inclusion in the directory by their state substance abuse agencies and that responded to the 1996 National Survey of Substance Abuse Treatment Services (N-SSATS). The information about each facility that appears in this directory was provided by that facility in response to the 1996 N-SSATS. The Substance Abuse and Mental Health Services Administration (SAMHSA) conducts the N-SSATS annually.